ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "Health Assessment Questionnaire"

  • Abstract Number: 552 • 2014 ACR/ARHP Annual Meeting

    Sustained Improvement in Physical Function, Health-Related Quality of Life, and Work Productivity with Adalimumab Treatment in Non-Radiographic Axial Spondyloarthritis

    Désirée van der Heijde1, Manish Mittal2, Naijun Chen2, Aileen L. Pangan2 and Avani D. Joshi2, 1Department of Rheumatology, Leiden University Medical Center, Leiden, Netherlands, 2AbbVie Inc., North Chicago, IL

    Background/Purpose: In the ABILITY-1 trial, adalimumab (ADA) treatment for 12 weeks was associated with improved clinical and health-related quality of life (HRQOL) outcomes among patients…
  • Abstract Number: 430 • 2014 ACR/ARHP Annual Meeting

    Minimally Important Difference in the European Quality of Life-Five Dimensions in Patients with Rheumatoid Arthritis

    Daisuke Hoshi, Eiichi Tanaka, Eisuke Inoue, Kumi Shidara, Yoko Shimizu, Akiko Kobayashi, Naoki Sugimoto, Eri Sato, Yohei Seto, Ayako Nakajima, Shigeki Momohara, Atsuo Taniguchi and Hisashi Yamanaka, Institute of Rheumatology, Tokyo Women’s Medical University, Tokyo, Japan

    Background/Purpose Patient-reported outcomes (PROs) have been recognized as important in evaluating disease status of rheumatoid arthritis (RA). The minimally important difference (MID) in PROs has…
  • Abstract Number: 417 • 2014 ACR/ARHP Annual Meeting

    Normal Scores of “0” (floor effects) Are Seen in 33-83% of Patients with Rheumatoid Arthritis (RA) on 8 HAQ Activities Which Also Are Found on the MDHAQ, but in Fewer Than 32% of Patients on 2 Unique MDHAQ Complex Activities “Walk 2 Miles or 3 Kilometers,” and “Participate in Recreation and Sports.”

    Isabel Castrejón1, Martin J. Bergman2, Kathryn A. Gibson3, John Meyerhoff4 and Theodore Pincus1, 1Rheumatology, Rush University Medical Center, Chicago, IL, 2Taylor Hospital, Ridley Park, PA, 3Liverpool Hospital, Liverpool, Australia, 4Sinai Hospital, Baltimore, MD

    Background/Purpose: Patients with rheumatoid arthritis (RA) have significantly better clinical status in recent years compared with previous decades.1 Health assessment questionnaire (HAQ) scores were almost…
  • Abstract Number: 197 • 2013 ACR/ARHP Annual Meeting

    Discordance Of Patient-Physician Assessments Of General Health In a US Hispanic Population With Rheumatoid Arthritis

    Leyda Díaz-Correa1, Mariely Nieves-Plaza2, Yesenia C. Santiago-Casas3, Tania González-Rivera4, Grissel Ríos3 and Luis M. Vilá3, 1Department of Medicine, University of Puerto Rico Medical Sciences Campus, San Juan, PR, 2University of Pittsburgh, Pittsburgh, PA, 3Department of Medicine, Division of Rheumatology, University of Puerto Rico Medical Sciences Campus, San Juan, PR, 4Department of Medicine, Division of Rheumatology, University of Michigan School of Medicine, Ann Arbor, MI

    Background/Purpose: Instruments to measure rheumatoid arthritis (RA) activity such as the 28-Joint Disease Activity Score (DAS28) are used to assess response to treatment. One component…
  • Abstract Number: 2459 • 2013 ACR/ARHP Annual Meeting

    Improvement In Physical Function, Health-Related Quality Of Life, and Work Productivity With Adalimumab Treatment In Non-Radiographic Axial Spondyloarthritis

    Désirée M. van Der Heijde1, Philip J. Mease2, Aileen L. Pangan3, Sumati A Rao3, Naijun Chen3 and Mary Cifaldi3, 1Dept of Rheumatology, Leiden University Medical Center, Leiden, Netherlands, 2Swedish Medical Center and University of Washington School of Medicine, Seattle, WA, 3AbbVie Inc., North Chicago, IL

    Background/Purpose: Adalimumab (ADA) was approved in the European Union for  the treatment of severe non-radiographic axial spondyloarthritis (nr-axSpA) in patients with objective signs of inflammation…
  • Abstract Number: 2272 • 2013 ACR/ARHP Annual Meeting

    Patient Survey Regarding Utility Of The Health Assessment Questionnaire Reveals An Unrecognized Aspect Of Disease Activity In Rheumatoid Arthritis: Consequences Of Physical Activity

    Kelly O'Neill Young1, Dana M. Symons1, Andrew T. Lumpe2 and Cynthia S. Crowson3, 1Rheumatoid Patient Foundation, Cocoa, FL, 2Seattle Pacific University, Seattle, WA, 3Department of Health Sciences Research, Mayo Clinic, Rochester, MN

    Patient Survey Regarding Utility of the Health Assessment Questionnaire Reveals an Unrecognized Aspect of Disease Activity in Rheumatoid Arthritis: Consequences of Physical Activity Background/Purpose: The…
  • Abstract Number: 2276 • 2013 ACR/ARHP Annual Meeting

    Does Socioeconomic Status Affect Outcomes In Early Rheumatoid Arthritis? Data From An Inception Cohort

    Grace Yang1, Vivian P. Bykerk2, J. Carter Thorne3, Gilles Boire4, Diane Tin5, Carol A. Hitchon6, Edward Keystone7, Boulos Haraoui8 and Janet E. Pope9, 1Medicine, Western University of Canada, London, ON, Canada, 2Medicine, Mount Sinai Hospital/University of Toronto, Toronto, ON, Canada, 3Southlake Regional Health Centre, Newmarket, ON, Canada, 4Rheumatology Division, Centre Hospitalier Universitaire de Sherbrooke, Université de Sherbrooke, Sherbrooke, QC, Canada, 5The Arthritis Program, Southlake Regional Health Centre, Newmarket, ON, Canada, 6Rheumatology, University of Manitoba, Winnipeg, MB, Canada, 7Rebecca MacDonald Centre for Arthritis and Autoimmune Disease, University of Toronto, Toronto, ON, Canada, 8Centre Hospitalier de l’Université de Montréal, Montreal, QC, Canada, 9St Joseph Health Care, London, ON, Canada

    Background/Purpose: Assess the impact of socioeconomic status (SES) on outcomes in patients with early inflammatory arthritis using data from the Canadian Early Arthritis Cohort (CATCH)…
  • Abstract Number: 1989 • 2013 ACR/ARHP Annual Meeting

    Determinants Of Functional Disability In Patients With Gout: Longitudinal Analysis From a Multicentre Observational Study Of The Italian Society For Rheumatology

    Carlo Alberto Scirè1, Maria Manara1, Greta Carrara1, Marco A. Cimmino2, Marcello Govoni3, Fausto Salaffi4, Leonardo Punzi5, Carlomaurizio Montecucco6, Marco Matucci-Cerinic7 and Giovanni Minisola8, 1Epidemiology Unit -Italian Society for Rheumatology, Milano, Italy, 2Research Laboratory and Academic Division of Clinical Rheumatology, Department of Internal Medicine, University of Genova, Genoa, Italy, 3Clinical and Experimental Medicine, Section of Rheumatology, University of Ferrara, Ferrara, Italy, 4Rheumatology Unit - Polytechnic University of the Marche, Jesi, Italy, 5Department of Medicine - DIMED, University of Padova, Padova, Italy, 6Rheumatology, University and IRCCS Policlinico S. Matteo Foundation, Pavia, Italy, 7Rheumatology, University of Florence, Azienda Ospedaliera Careggi, Florence, Italy, 8Rheumatology Unit, San Camillo-Forlanini Hospital, Rome, Italy

    Background/Purpose: Gout is the most prevalent arthritis and significantly impacts on function. Beside the influence of concurrent comorbidities, identifying disease-related prognostic factors may help to…
  • Abstract Number: 1984 • 2013 ACR/ARHP Annual Meeting

    Impact Of Educational Attainment On Health-Related Quality Of Life and Healthcare Utilization Among Veterans With Gout

    Cleopatra Aquino-Beaton1, Jay E. Persselin2, Ari Weinreb1, Meika A Fang1, Jasvinder A. Singh3,4, Erin Duffy5, David Elashoff6, Puja Khanna7,8 and Dinesh Khanna9, 1Rheumatology, VA Greater Los Angeles Healthcare System, Los Angeles, CA, 2Medicine W-111J Div of Rheum, VA Greater Los Angeles Healthcare System, Los Angeles, CA, 3Department of Medicine, University of Alabama, Tuscaloosa, AL, 4Rheumatology, Birmingham VA, Birmingham, AL, 5Medicine, University of California Los Angeles, Los Angeles, CA, 6Medicine- Statistic Core, UCLA Department of Medicine Statistics Core, Los Angeles, CA, 7Division of Rheumatology/Dept. of Internal Medicine, University of Michigan Medical Center, Ann Arbor, MI, 8Rheumatology, Ann Arbor VA, Ann Arbor, MI, 9Division of Rheumatology, University of Michigan Medical Center, Ann Arbor, MI

    Background/Purpose: Gout is a debilitating, chronic disease that requires ongoing treatment and effective self-management. Successful gout treatment depends on multiple factors, including educational attainment. Adequate…
  • Abstract Number: 1934 • 2013 ACR/ARHP Annual Meeting

    Scores On The Multidimensional Health Assessment Questionnaire (MDHAQ) For “Walk 2 Miles Or 3 Kilometers,” “Poor Sleep,” and “Participate In Recreation,” Are Higher, Indicating Poorer Status, Than Scores For 8 Activities Derived From The Health Assessment Questionnaire (HAQ)

    Kathryn Gibson1, Sung-Hoon Park2,3 and Theodore Pincus4, 1Liverpool Hospital and University of New South Wales, Sydney, Australia, 2NYU Hospital for Joint Diseases and New York University School of Medicine, New York, NY, 3Catholic University of Daegu School of Medicine, Daegu, South Korea, 4Rheumatology, Rush University Medical Center, Chicago, IL

    Background/Purpose: The HAQ [Arthritis Rheum 1980;23:137] has been used in almost all rheumatoid arthritis (RA) clinical trials conducted over the last two decades, and provides…
  • Abstract Number: 1342 • 2013 ACR/ARHP Annual Meeting

    Prognosis In Espoir Rheumatoid Arthritis Cohort At 24 Months According To Remission Status At 12 Months: No Differences In Radiographic Scores According To Prior Remission Status, But Significant Differences In HAQ Scores, Highest For Boolean and RAPID3RJ1 Criteria

    Isabel Castrejón1, Maxime Dougados2, Bernard Combe3, Francis Guillemin4, Bruno Fautrel5 and Theodore Pincus1, 1Rheumatology, Rush University Medical Center, Chicago, IL, 2Cochin Hospital, Paris, France, 3CHU Lapeyronie, Montpellier, France, 4Hopitaux de Brabois, Nancy, France, 5APHP, Pitié-Salpêtrière University Hospital, Paris, France

    Background/Purpose: Different criteria for remission in rheumatoid arthritis (RA) have been developed from a Core Data Set of 7 measures for the DAS28, SDAI, CDAI…
  • Abstract Number: 1216 • 2013 ACR/ARHP Annual Meeting

    Risk Factors Associated With Fracture Occurrence Appear to Differ Between Distal Radius, Clinical Vertebral, and Hip Fractures in Japanese Patients With Rheumatoid Arthritis: A Prospective Observational Cohort Study

    Kensuke Ochi1, Takefumi Furuya1, Yuki Go1, Eisuke Inoue2, Katsunori Ikari1, Atsuo Taniguchi2, Hisashi Yamanaka1 and Shigeki Momohara2, 1Institute of Rheumatology, Tokyo Women's Medical University, Tokyo, Japan, 2Institute of Rheumatology, Tokyo Women’s Medical University, Tokyo, Japan

    Background/Purpose: Patients with rheumatoid arthritis (RA) are at high risk of developing fractures. Previously, utilizing data from our Institute of Rheumatology Rheumatoid Arthritis (IORRA) cohort…
  • Abstract Number: 1217 • 2013 ACR/ARHP Annual Meeting

    Determination Of Vitamin D Level Prior To The Initiation Of Bisphosphonate Therapy

    Chris T. Derk1, Ruchika Patel2, Rennie L. Rhee2, Yiu Tak Leung1, R. Michelle Koolaee2, Shiv Sehra2 and Ashwini Komarla3, 1Medicine/Rheumatology, University of Pennsylvania, Philadelphia, PA, 2Rheumatology, University of Pennsylvania, Philadelphia, PA, 3University of Pennsylvania, Philadelphia, PA

    Background/Purpose: Vitamin D deficiency is under-recognized and in 18-35% of patients who do not respond to bisphosphonates, concurrent use of vitamin D 1000 units daily…
  • Abstract Number: 995 • 2013 ACR/ARHP Annual Meeting

    Quality Of Life, Productivity Impairment, Disease Severity and Health Care Costs In Relation To Functional Impairment In Psoriatic Arthritis Patients In The Czech Republic

    Jiri Stolfa1,2, Liliana Sedova1,2, David Suchy3, Jiri Klimes4, Milan Vocelka4 and Tomas Dolezal4, 1Institute of Rheumatology, Prague, Czech Republic, 2Clinic of Rheumatology, Charles University Prague, Prague, Czech Republic, 3Department of Clinical Pharmacology, Rheumatology, University hospital Plzen, Plzen, Czech Republic, 4Institute of Health Economics and Technology Assessment, Charles University, Prague, Czech Republic

    Background/Purpose: Our aim was to describe the QoL, productivity impairment, clinical indicators and health care costs in relationship to functional status described by Health assessment…
  • Abstract Number: 191 • 2013 ACR/ARHP Annual Meeting

    Does Specific Joint Involvement In Rheumatoid Arthritis Patients Predict Patient Reported Outcomes?  Implications For Clinical Practice

    Regan Arendse1, William G. Bensen2, Andrew Chow3, Jude F. Rodrigues4, Sanjay Dixit5, Dalton E. Sholter6, Philip Baer7, Milton F. Baker8, Denis Choquette9, Isabelle Fortin10, Algis Jovaisas11, Emmanouil Rampakakis12, John S. Sampalis12, Francois Nantel13, Susan M. Otawa14, May Shawi15 and Allen J. Lehman14, 1University of Saskatchewan, Saskatoon, SK, Canada, 2Department of Medicine, Division of Rheumatology, Clinical Professor, McMaster University, Hamilton, ON, Canada, 3University of Toronto, McMaster University, Credit Valley Rheumatology, Mississauga, ON, Canada, 4Rheumatology, Windsor, ON, Canada, 5McMaster University, Hamilton, ON, Canada, 6Rheumatology Associates, Edmonton, AB, Canada, 7Private Practice, Scarborough, ON, Canada, 8University of Victoria, Victoria, BC, Canada, 9Rheumatology, Institut de rhumatologie de Montréal (IRM), Montréal, QC, Canada, 10Centre de rhumatologie de l'est du Québec (CREQ), Rimouski, QC, Canada, 11Division of Rheumatology, University of Ottawa, Ottawa, ON, Canada, 12JSS Medical Research, Montreal, QC, Canada, 13Janssen Inc., Toronto, ON, Canada, 14Medical Affairs, Janssen Inc., Toronto, ON, Canada, 15Medical Affairs, Janssen Canada Inc, Toronto, ON, Canada

    Background/Purpose: Assessment of functional (dis)ability in rheumatoid arthritis (RA) is subject to patient judgment when appraising their ability to do daily activities. The aim of…
  • « Previous Page
  • 1
  • …
  • 3
  • 4
  • 5
  • 6
  • 7
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology